Literature DB >> 34984159

Pulmonary Embolism as a Finding During Endobronchial Ultrasound: An Occasional Occurrence or a New Element to Be Staged?

Alberto Fantin1, Nadia Castaldo2, Benjamin Seides3, Maria Majori4.   

Abstract

In this report, we describe two cases of lung cancer-related pulmonary embolism (PE), both encountered while performing an endobronchial ultrasound (EBUS). We propose EBUS as a diagnostic and confirmatory method for PE detection during the staging of lung cancer.
Copyright © 2021, Fantin et al.

Entities:  

Keywords:  ebus; nsclc; pulmonary artery; pulmonary emboli; staging

Year:  2021        PMID： 34984159      PMCID： PMC8720493          DOI： 10.7759/cureus.20137

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  5 in total

1.  EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism.

Authors:  J S Park; J-H Chung; S Jheon; D-J Choi; H I Yoon; J H Lee; C-T Lee; S W Lee
Journal:  Eur Respir J       Date:  2011-12       Impact factor: 16.671

Review 2.  Preoperative Evaluation of Patients Undergoing Lung Resection Surgery: Defining the Role of the Anesthesiologist on a Multidisciplinary Team.

Authors:  Giorgio Della Rocca; Luigi Vetrugno; Cecilia Coccia; Federico Pierconti; Roberto Badagliacca; Carmine Dario Vizza; Maria Papale; Enrico Melis; Francesco Facciolo
Journal:  J Cardiothorac Vasc Anesth       Date:  2015-12-01       Impact factor: 2.628

3.  Transbronchial Endovascular Biopsy of Septic Thrombophlebitis.

Authors:  Edward T Qian; Robert J Lentz
Journal:  J Bronchology Interv Pulmonol       Date:  2021-08-04

4.  The incidence of pulmonary embolism and associated FDG-PET findings in IV contrast-enhanced PET/CT.

Authors:  Robert R Flavell; Spencer C Behr; Ryan L Brunsing; David M Naeger; Miguel Hernandez Pampaloni
Journal:  Acad Radiol       Date:  2014-06       Impact factor: 3.173

5.  Endobronchial ultrasound as a confirmatory tool for the diagnosis of pulmonary embolism.

Authors:  Kassem Harris; Michel Chalhoub
Journal:  Ann Thorac Med       Date:  2014-04       Impact factor: 2.219
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.